- Home
- ULY vs HOTH Comparison
ULY vs HOTH Comparison
Compare ULY & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- HOTH
- Stock Information
- Founded
- ULY 2013
- HOTH 2017
- Country
- ULY United States
- HOTH United States
- Employees
- ULY N/A
- HOTH N/A
- Industry
- ULY
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- ULY
- HOTH Health Care
- Exchange
- ULY Nasdaq
- HOTH Nasdaq
- Market Cap
- ULY 6.7M
- HOTH 4.9M
- IPO Year
- ULY N/A
- HOTH 2019
- Fundamental
- Price
- ULY $0.48
- HOTH $0.78
- Analyst Decision
- ULY Strong Buy
- HOTH Strong Buy
- Analyst Count
- ULY 1
- HOTH 4
- Target Price
- ULY $1.50
- HOTH $4.75
- AVG Volume (30 Days)
- ULY 346.1K
- HOTH 566.2K
- Earning Date
- ULY 11-12-2024
- HOTH 01-07-2025
- Dividend Yield
- ULY N/A
- HOTH N/A
- EPS Growth
- ULY N/A
- HOTH N/A
- EPS
- ULY 7.18
- HOTH N/A
- Revenue
- ULY $155,926,000.00
- HOTH N/A
- Revenue This Year
- ULY N/A
- HOTH N/A
- Revenue Next Year
- ULY $20.40
- HOTH N/A
- P/E Ratio
- ULY $0.07
- HOTH N/A
- Revenue Growth
- ULY N/A
- HOTH N/A
- 52 Week Low
- ULY $0.41
- HOTH $0.58
- 52 Week High
- ULY $3.45
- HOTH $1.69
- Technical
- Relative Strength Index (RSI)
- ULY 38.34
- HOTH 44.21
- Support Level
- ULY $0.44
- HOTH $0.71
- Resistance Level
- ULY $0.53
- HOTH $0.84
- Average True Range (ATR)
- ULY 0.06
- HOTH 0.05
- MACD
- ULY -0.00
- HOTH -0.00
- Stochastic Oscillator
- ULY 20.87
- HOTH 51.34
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.